Jeffrey G. Black's most recent trade in Exagen Inc was a trade of 15,000 Common Stock done . Disclosure was reported to the exchange on Feb. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exagen Inc | Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 15,000 | 289,492 (2%) | 0% | 0 | Common Stock | |
| Exagen Inc | Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 10,000 | 10,000 | - | - | Stock Option(right to buy) | |
| Exagen Inc | Jeffrey G. Black | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 15 Nov 2024 | 22,298 | 274,492 (2%) | 0% | 3.0 | 66,448 | Common Stock |
| Exagen Inc | Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 225,000 | 252,194 (2%) | 1% | 0 | Common Stock | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 20 Aug 2024 | 6,690 | 421,608 (0%) | 0% | 1.9 | 12,778 | Common Stock |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 13,157 | 432,993 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 13,157 | 144,738 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. | 15 Aug 2024 | 4,695 | 428,298 (0%) | 0% | 1.5 | 7,277 | Common Stock |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 300,000 | 419,836 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 52,631 | 138,615 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 52,631 | 157,895 | - | - | Common Stock | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.54 per share. | 15 May 2024 | 18,779 | 119,836 (0%) | 0% | 2.5 | 47,699 | Common Stock |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 18 May 2023 | 43,492 | 43,492 (0%) | 0% | 2.2 | 96,365 | Common Stock |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 18 May 2023 | 42,492 | 85,984 (0%) | 0% | 2.3 | 97,213 | Common Stock |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Jeffrey G. Black | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 210,526 | 210,526 | - | - | Restricted Stock Units | |
| Alphatec Holdings Inc | Jeffrey G. Black | EVP & CFO | Sale of securities on an exchange or to another person at price $ 16.69 per share. | 09 Mar 2021 | 7,000 | 620,770 (1%) | 0% | 16.7 | 116,830 | Common Stock |
| Alphatec Holdings Inc | Jeffrey G. Black | EVP & CFO | Sale of securities on an exchange or to another person at price $ 16.28 per share. | 16 Feb 2021 | 25,000 | 627,770 (1%) | 0% | 16.3 | 407,000 | Common Stock |
| Alphatec Holdings Inc | Jeffrey G. Black | EVP & CFO | Sale of securities on an exchange or to another person at price $ 6.42 per share. | 11 Aug 2020 | 5,000 | 652,770 (1%) | 0% | 6.4 | 32,100 | Common Stock |
| Alphatec Holdings Inc | Jeffrey G. Black | EVP & CFO | Sale of securities on an exchange or to another person at price $ 5.03 per share. | 04 Aug 2020 | 8,929 | 657,770 (1%) | 0% | 5.0 | 44,913 | Common Stock |